Skip to main content
Top
Published in: Respiratory Research 1/2014

Open Access 01-12-2014 | Research

Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD

Authors: Philippe Gagnon, Bruno B Lemire, Annie Dubé, Didier Saey, Alexandra Porlier, Marilie Croteau, Steeve Provencher, Richard Debigaré, François Maltais

Published in: Respiratory Research | Issue 1/2014

Login to get access

Abstract

Background

Little is known about limb muscle abnormalities in mild COPD. Inactivity and systemic inflammation could play a role in the development of limb muscle dysfunction in COPD. The objective of the present study was to characterize quadriceps function, enzymatic activities and morphometry, levels of plasma inflammatory markers and physical activity levels in daily life (PAdl) in patients with mild COPD (GOLD 1).

Methods

Mid-thigh muscle cross-sectional area (MTCSA), quadriceps strength, endurance, fiber-type distribution, capillarity, pro-angiogenesis factors (VEGF-A, angiopoietin I and II) and muscle oxidative capacity were assessed in 37 patients with mild COPD and 19 controls. Systemic inflammatory markers (CRP, IL-6, TNF-α, Fibrinogen, SP-D) and PAdl were assessed.

Results

MTCSA, quadriceps strength and endurance were not different between COPD and controls. Capillarity and muscle oxidative capacity were all preserved in mild COPD. Reduced pro-angiogenesis factor mRNA expression was seen in COPD. The level of moderately active intensity (>3 METs) was significantly lower in mild COPD and, in multiple regression analyses, the level of physical activity was a determinant of muscle oxidative capacity and capillarization. No between-group differences were found regarding muscle oxidative stress while circulating IL-6 levels were elevated in mild COPD.

Conclusions

The quadriceps muscle function was preserved in mild COPD although a reduced potential for angiogenesis was found. The reduced level of daily activities and evidence of systemic inflammation in these individuals suggest that these factors precede the development of overt limb muscle dysfunction in COPD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Debigaré R, Maltais F: The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol. 2008, 105: 751-753. 10.1152/japplphysiol.90336.2008a.PubMedCrossRef Debigaré R, Maltais F: The major limitation to exercise performance in COPD is lower limb muscle dysfunction. J Appl Physiol. 2008, 105: 751-753. 10.1152/japplphysiol.90336.2008a.PubMedCrossRef
2.
go back to reference Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 158: 629-634. 10.1164/ajrccm.158.2.9711023.PubMedCrossRef Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F: Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 158: 629-634. 10.1164/ajrccm.158.2.9711023.PubMedCrossRef
3.
go back to reference Hamilton AL, Killian KJ, Summers E, Jones NL: Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995, 152: 2021-2031. 10.1164/ajrccm.152.6.8520771.PubMedCrossRef Hamilton AL, Killian KJ, Summers E, Jones NL: Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med. 1995, 152: 2021-2031. 10.1164/ajrccm.152.6.8520771.PubMedCrossRef
4.
go back to reference Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, Préfaut C: Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax. 2005, 60: 834-841. 10.1136/thx.2004.037531.PubMedPubMedCentralCrossRef Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, Préfaut C: Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax. 2005, 60: 834-841. 10.1136/thx.2004.037531.PubMedPubMedCentralCrossRef
5.
go back to reference Mador MJ, Deniz O, Aggarwal A, Kufel TJ: Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003, 168: 102-108. 10.1164/rccm.200202-080OC.PubMedCrossRef Mador MJ, Deniz O, Aggarwal A, Kufel TJ: Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003, 168: 102-108. 10.1164/rccm.200202-080OC.PubMedCrossRef
6.
go back to reference Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F: Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998, 30: 1467-1474. 10.1097/00005768-199810000-00001.PubMedCrossRef Whittom F, Jobin J, Simard PM, Leblanc P, Simard C, Bernard S, Belleau R, Maltais F: Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998, 30: 1467-1474. 10.1097/00005768-199810000-00001.PubMedCrossRef
7.
go back to reference Jobin J, Maltais F, Doyon JF, Leblanc P, Simard PM, Simard AA, Simard C: Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil. 1998, 18: 432-437. 10.1097/00008483-199811000-00005.PubMedCrossRef Jobin J, Maltais F, Doyon JF, Leblanc P, Simard PM, Simard AA, Simard C: Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. J Cardiopulm Rehabil. 1998, 18: 432-437. 10.1097/00008483-199811000-00005.PubMedCrossRef
8.
go back to reference Jatta K, Eliason G, Portela-Gomes GM, Grimelius L, Caro O, Nilholm L, Sirjso A, Piehl-Aulin K, Abdel-Halim SM: Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease. J Clin Pathol. 2009, 62: 70-76. 10.1136/jcp.2008.057190.PubMedCrossRef Jatta K, Eliason G, Portela-Gomes GM, Grimelius L, Caro O, Nilholm L, Sirjso A, Piehl-Aulin K, Abdel-Halim SM: Overexpression of von Hippel-Lindau protein in skeletal muscles of patients with chronic obstructive pulmonary disease. J Clin Pathol. 2009, 62: 70-76. 10.1136/jcp.2008.057190.PubMedCrossRef
9.
go back to reference Maltais F, Jobin J, Sullivan MJ, Bernard S, Whittom F, Killian KJ, Desmeules M, Bélanger M, Leblanc P: Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol. 1998, 84: 1573-1580.PubMed Maltais F, Jobin J, Sullivan MJ, Bernard S, Whittom F, Killian KJ, Desmeules M, Bélanger M, Leblanc P: Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol. 1998, 84: 1573-1580.PubMed
10.
go back to reference Saey D, Lemire BB, Gagnon P, Bombardier E, Tupling AR, Debigaré R, Côté CH, Maltais F: Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease. J Appl Physiol. 2011, 110: 116-124. 10.1152/japplphysiol.00153.2010.PubMedCrossRef Saey D, Lemire BB, Gagnon P, Bombardier E, Tupling AR, Debigaré R, Côté CH, Maltais F: Quadriceps metabolism during constant workrate cycling exercise in chronic obstructive pulmonary disease. J Appl Physiol. 2011, 110: 116-124. 10.1152/japplphysiol.00153.2010.PubMedCrossRef
11.
go back to reference Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996, 153: 976-980. 10.1164/ajrccm.153.3.8630582.PubMedCrossRef Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996, 153: 976-980. 10.1164/ajrccm.153.3.8630582.PubMedCrossRef
12.
go back to reference Marquis K, Debigaré R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F: Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002, 166: 809-813. 10.1164/rccm.2107031.PubMedCrossRef Marquis K, Debigaré R, Lacasse Y, Leblanc P, Jobin J, Carrier G, Maltais F: Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002, 166: 809-813. 10.1164/rccm.2107031.PubMedCrossRef
13.
go back to reference Remels AH, Gosker HR, Langen RC, Schols AM: The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol. 2013, 114: 1253-1262. 10.1152/japplphysiol.00790.2012.PubMedCrossRef Remels AH, Gosker HR, Langen RC, Schols AM: The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol. 2013, 114: 1253-1262. 10.1152/japplphysiol.00790.2012.PubMedCrossRef
14.
go back to reference Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013, 187: 347-365. 10.1164/rccm.201204-0596PP.PubMedCrossRef
15.
go back to reference Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984, 85: 751-758. 10.1378/chest.85.6.751.PubMedCrossRef Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984, 85: 751-758. 10.1378/chest.85.6.751.PubMedCrossRef
16.
go back to reference American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (ATS). Am J Respir Crit Care Med. 1995, 152: S77-S121. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (ATS). Am J Respir Crit Care Med. 1995, 152: S77-S121.
17.
go back to reference Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl. 1993, 16: 5-40.PubMedCrossRef
18.
go back to reference Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159: 179-187. 10.1164/ajrccm.159.1.9712108.PubMedCrossRef Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999, 159: 179-187. 10.1164/ajrccm.159.1.9712108.PubMedCrossRef
19.
go back to reference Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, Provencher S, Maltais F: Impact of pre-induced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. J Appl Physiol. 2009, 107: 832-840. 10.1152/japplphysiol.91546.2008.PubMedCrossRef Gagnon P, Saey D, Vivodtzev I, Laviolette L, Mainguy V, Milot J, Provencher S, Maltais F: Impact of pre-induced quadriceps fatigue on exercise response in chronic obstructive pulmonary disease and healthy subjects. J Appl Physiol. 2009, 107: 832-840. 10.1152/japplphysiol.91546.2008.PubMedCrossRef
20.
go back to reference Allaire J, Maltais F, Doyon JF, Noël M, Leblanc P, Carrier G, Simard C, Jobin J: Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax. 2004, 59: 673-678. 10.1136/thx.2003.020636.PubMedPubMedCentralCrossRef Allaire J, Maltais F, Doyon JF, Noël M, Leblanc P, Carrier G, Simard C, Jobin J: Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD. Thorax. 2004, 59: 673-678. 10.1136/thx.2003.020636.PubMedPubMedCentralCrossRef
21.
go back to reference Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992, 47: 1019-1024. 10.1136/thx.47.12.1019.PubMedPubMedCentralCrossRef Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE: Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax. 1992, 47: 1019-1024. 10.1136/thx.47.12.1019.PubMedPubMedCentralCrossRef
22.
go back to reference Bergström J: Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients and patients with chronic diarrhoea. Scand J Clin Lab Invest. 1962, 14: 110- Bergström J: Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients and patients with chronic diarrhoea. Scand J Clin Lab Invest. 1962, 14: 110-
23.
go back to reference Blomstrand E, Celsing F, Friden J, Ekblom B: How to calculate human muscle fibre areas in biopsy samples–methodological considerations. Acta Physiol Scand. 1984, 122: 545-551. 10.1111/j.1748-1716.1984.tb07543.x.PubMedCrossRef Blomstrand E, Celsing F, Friden J, Ekblom B: How to calculate human muscle fibre areas in biopsy samples–methodological considerations. Acta Physiol Scand. 1984, 122: 545-551. 10.1111/j.1748-1716.1984.tb07543.x.PubMedCrossRef
24.
go back to reference Ferrari R, Tanni SE, Caram LM, Correa C, Correa CR, Godoy I: Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res. 2013, 14: 24-10.1186/1465-9921-14-24.PubMedPubMedCentralCrossRef Ferrari R, Tanni SE, Caram LM, Correa C, Correa CR, Godoy I: Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease. Respir Res. 2013, 14: 24-10.1186/1465-9921-14-24.PubMedPubMedCentralCrossRef
25.
go back to reference Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, et al: Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185: 1065-1072. 10.1164/rccm.201110-1792OC.PubMedCrossRef Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Calverley P, Coxson H, Crim C, Edwards LD, et al: Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185: 1065-1072. 10.1164/rccm.201110-1792OC.PubMedCrossRef
26.
go back to reference Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, Wouters EF: The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010, 36: 81-88. 10.1183/09031936.00104909.PubMedPubMedCentralCrossRef Seymour JM, Spruit MA, Hopkinson NS, Natanek SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, Wouters EF: The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J. 2010, 36: 81-88. 10.1183/09031936.00104909.PubMedPubMedCentralCrossRef
27.
go back to reference Gosker HR, Zeegers MP, Wouters EF, Schols AM: Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax. 2007, 62: 944-949. 10.1136/thx.2007.078980.PubMedPubMedCentralCrossRef Gosker HR, Zeegers MP, Wouters EF, Schols AM: Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax. 2007, 62: 944-949. 10.1136/thx.2007.078980.PubMedPubMedCentralCrossRef
28.
go back to reference Eliason G, Abdel-Halim S, Arvidsson B, Kadi F, Piehl-Aulin K: Physical performance and muscular characteristics in different stages of COPD. Scand J Med Sci Sport. 2009, 19: 865-870. 10.1111/j.1600-0838.2008.00858.x.CrossRef Eliason G, Abdel-Halim S, Arvidsson B, Kadi F, Piehl-Aulin K: Physical performance and muscular characteristics in different stages of COPD. Scand J Med Sci Sport. 2009, 19: 865-870. 10.1111/j.1600-0838.2008.00858.x.CrossRef
29.
go back to reference Doucet M, Debigaré R, Joanisse DR, Côté C, Leblanc P, Gregoire J, Deslauriers J, Vaillancourt R, Maltais F: Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J. 2004, 24: 971-979. 10.1183/09031936.04.00020204.PubMedCrossRef Doucet M, Debigaré R, Joanisse DR, Côté C, Leblanc P, Gregoire J, Deslauriers J, Vaillancourt R, Maltais F: Adaptation of the diaphragm and the vastus lateralis in mild-to-moderate COPD. Eur Respir J. 2004, 24: 971-979. 10.1183/09031936.04.00020204.PubMedCrossRef
30.
go back to reference Eliason G, Abdel-Halim SM, Piehl-Aulin K, Kadi F: Alterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease. Respir Res. 2010, 11: 97-10.1186/1465-9921-11-97.PubMedPubMedCentralCrossRef Eliason G, Abdel-Halim SM, Piehl-Aulin K, Kadi F: Alterations in the muscle-to-capillary interface in patients with different degrees of chronic obstructive pulmonary disease. Respir Res. 2010, 11: 97-10.1186/1465-9921-11-97.PubMedPubMedCentralCrossRef
31.
go back to reference Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J: Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax. 2008, 63: 100-107.PubMedCrossRef Barreiro E, Schols AM, Polkey MI, Galdiz JB, Gosker HR, Swallow EB, Coronell C, Gea J: Cytokine profile in quadriceps muscles of patients with severe COPD. Thorax. 2008, 63: 100-107.PubMedCrossRef
32.
go back to reference Mofarrahi M, Sigala I, Vassilakopoulos T, Harel S, Guo Y, Debigare R, Maltais F, Hussain SN: Angiogenesis-related factors in skeletal muscles of copd patients: roles of angiopoietin 2. J Appl Physiol. 2013, 114 (9): 1309-1318. 10.1152/japplphysiol.00954.2012.PubMedCrossRef Mofarrahi M, Sigala I, Vassilakopoulos T, Harel S, Guo Y, Debigare R, Maltais F, Hussain SN: Angiogenesis-related factors in skeletal muscles of copd patients: roles of angiopoietin 2. J Appl Physiol. 2013, 114 (9): 1309-1318. 10.1152/japplphysiol.00954.2012.PubMedCrossRef
33.
go back to reference Gavin TP: Basal and exercise-induced regulation of skeletal muscle capillarization. Exerc Sports Sci Rev. 2009, 37: 86-92. 10.1097/JES.0b013e31819c2e9b.CrossRef Gavin TP: Basal and exercise-induced regulation of skeletal muscle capillarization. Exerc Sports Sci Rev. 2009, 37: 86-92. 10.1097/JES.0b013e31819c2e9b.CrossRef
34.
go back to reference Fang S, Pentinmikko N, Ilmonen M, Salven P: Dual action of TGF-beta induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells. Angiogenesis. 2012, 15: 511-519. 10.1007/s10456-012-9278-9.PubMedCrossRef Fang S, Pentinmikko N, Ilmonen M, Salven P: Dual action of TGF-beta induces vascular growth in vivo through recruitment of angiogenic VEGF-producing hematopoietic effector cells. Angiogenesis. 2012, 15: 511-519. 10.1007/s10456-012-9278-9.PubMedCrossRef
35.
go back to reference Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O’Brien SM, Davis RB, Gowen LC, et al: VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006, 290: H560-H576.PubMedCrossRef Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O’Brien SM, Davis RB, Gowen LC, et al: VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006, 290: H560-H576.PubMedCrossRef
36.
go back to reference Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M: Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest. 2007, 37: 897-904. 10.1111/j.1365-2362.2007.01867.x.PubMedCrossRef Crul T, Spruit MA, Gayan-Ramirez G, Quarck R, Gosselink R, Troosters T, Pitta F, Decramer M: Markers of inflammation and disuse in vastus lateralis of chronic obstructive pulmonary disease patients. Eur J Clin Invest. 2007, 37: 897-904. 10.1111/j.1365-2362.2007.01867.x.PubMedCrossRef
37.
go back to reference Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, et al: Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012, 7: e37483-10.1371/journal.pone.0037483.PubMedPubMedCentralCrossRef Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, et al: Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012, 7: e37483-10.1371/journal.pone.0037483.PubMedPubMedCentralCrossRef
38.
go back to reference Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011, 12: 146-10.1186/1465-9921-12-146.PubMedPubMedCentralCrossRef Dickens JA, Miller BE, Edwards LD, Silverman EK, Lomas DA, Tal-Singer R: COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir Res. 2011, 12: 146-10.1186/1465-9921-12-146.PubMedPubMedCentralCrossRef
39.
go back to reference Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, Walsh SL, Bloch SA, Sidhu PS, Hart N, et al: Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012, 40: 1115-1122. 10.1183/09031936.00170111.PubMedCrossRef Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, Walsh SL, Bloch SA, Sidhu PS, Hart N, et al: Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012, 40: 1115-1122. 10.1183/09031936.00170111.PubMedCrossRef
40.
go back to reference van den Borst B, Koster A, Yu B, Gosker HR, Meibohm B, Bauer DC, Kritchevsky SB, Liu Y, Newman AB, Harris TB, Schols AM: Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?. Thorax. 2011, 66: 961-969. 10.1136/thoraxjnl-2011-200010.PubMedPubMedCentralCrossRef van den Borst B, Koster A, Yu B, Gosker HR, Meibohm B, Bauer DC, Kritchevsky SB, Liu Y, Newman AB, Harris TB, Schols AM: Is age-related decline in lean mass and physical function accelerated by obstructive lung disease or smoking?. Thorax. 2011, 66: 961-969. 10.1136/thoraxjnl-2011-200010.PubMedPubMedCentralCrossRef
41.
go back to reference Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, Benzo R, Andre D, Weisman I, Decramer M: Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010, 104: 1005-1011. 10.1016/j.rmed.2010.01.012.PubMedPubMedCentralCrossRef Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L, Benzo R, Andre D, Weisman I, Decramer M: Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010, 104: 1005-1011. 10.1016/j.rmed.2010.01.012.PubMedPubMedCentralCrossRef
42.
go back to reference Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33: 262-272.PubMedCrossRef Watz H, Waschki B, Meyer T, Magnussen H: Physical activity in patients with COPD. Eur Respir J. 2009, 33: 262-272.PubMedCrossRef
43.
go back to reference Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Smith C, Man WD, Tal-Singer R, Edwards LD, et al: Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med. 2012, 106: 522-530. 10.1016/j.rmed.2011.10.022.PubMedCrossRef Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, Groenen M, Smith C, Man WD, Tal-Singer R, Edwards LD, et al: Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med. 2012, 106: 522-530. 10.1016/j.rmed.2011.10.022.PubMedCrossRef
44.
go back to reference Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, Zakynthinos S, Roussos C: Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest. 2005, 128: 3838-3845. 10.1378/chest.128.6.3838.PubMedCrossRef Vogiatzis I, Terzis G, Nanas S, Stratakos G, Simoes DC, Georgiadou O, Zakynthinos S, Roussos C: Skeletal muscle adaptations to interval training in patients with advanced COPD. Chest. 2005, 128: 3838-3845. 10.1378/chest.128.6.3838.PubMedCrossRef
45.
go back to reference Vogiatzis I, Terzis G, Stratakos G, Cherouveim E, Athanasopoulos D, Spetsioti S, Nasis I, Manta P, Roussos C, Zakynthinos S: Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest. 2011, 140: 744-752. 10.1378/chest.10-3058.PubMedCrossRef Vogiatzis I, Terzis G, Stratakos G, Cherouveim E, Athanasopoulos D, Spetsioti S, Nasis I, Manta P, Roussos C, Zakynthinos S: Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest. 2011, 140: 744-752. 10.1378/chest.10-3058.PubMedCrossRef
Metadata
Title
Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD
Authors
Philippe Gagnon
Bruno B Lemire
Annie Dubé
Didier Saey
Alexandra Porlier
Marilie Croteau
Steeve Provencher
Richard Debigaré
François Maltais
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2014
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-15-4

Other articles of this Issue 1/2014

Respiratory Research 1/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.